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Gnathodiaphyseal dysplasia (GDD) is a rare skeletal syndrome characterized by bone fragility, sclerosis of tubular
bones, and cemento-osseous lesions of the jawbone. By linkage analysis of a large Japanese family with GDD, we
previously mapped the GDD locus to chromosome 11p14.3-15.1. In the critical region determined by recombination
mapping, we identiﬁed a novel gene (GDD1) that encodes a 913-amino-acid protein containing eight putative
transmembrane-spanning domains. Two missense mutations (C356R and C356G) of GDD1 were identiﬁed in the
two families with GDD (the original Japanese family and a new African American family), and both missense
mutations occur at the cysteine residue at amino acid 356, which is evolutionarily conserved among human, mouse,
zebraﬁsh, fruit ﬂy, and mosquito. Cellular localization to the endoplasmic reticulum suggests a role for GDD1 in
the regulation of intracellular calcium homeostasis.
In 1969, Akasaka et al. described a large Japanese family
including 21 patients exhibiting frequent bone fractures
in adolescence and purulent osteomyelitis of the jaws
during adult life, with autosomal dominant inheritance.
In this family, patients experienced frequent bone frac-
tures caused by trivial accidents in childhood; however,
the fractures healed normally without bone deformity.
The jaw lesions in patients replace the tooth-bearing
segments of the maxilla and mandible with ﬁbrous con-
nective tissues, including various amounts of cementum-
like calciﬁed mass, sometimes causing facial deformities
(ﬁg. 1A and 1B). Patients also have a propensity for jaw
infection and often suffer from purulent osteomyelitis-
like symptoms, such as swelling of and pus discharge
from the gums, mobility of the teeth, insufﬁcient healing
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after tooth extraction, and exposure of the lesions into
the oral cavity. Extragnathic skeletal changes consist of
generalized coarse bony trabeculae and gross thickening
of the diaphyseal cortices of long bones (ﬁg. 1C and
1D). This syndrome was named “hereditary gnatho-di-
aphyseal sclerosis” (Akasaka et al. 1969), because it was
distinguished from known systemic bone diseases by co-
incidence of bone fragility, sclerosis of tubular bones,
cemento-osseous lesions of the jawbone, and no abnor-
mality in nonskeletal tissues. In 1985, Levin et al. in-
dependently described three families—whose condition
shared many features with that reported by Akasaka et
al.—as having “osteogenesis imperfecta with unusual
skeletal lesions” (MIM 166260) (Levin et al. 1985). Spo-
radic cases with similar clinical manifestations have also
been reported (Colavita et al. 1984; Nishimura et al.
1996). More recently, Riminucci et al. proposed to name
this disease entity “gnathodiaphyseal dysplasia (GDD),”
because osteosclerosis is not a feature of the jaw lesions
of these patients (Riminucci et al. 2001).
By linkage analysis of the Japanese family reported by
Akasaka et al., we previously mapped the GDD locus
to a 8.7-cM interval on chromosome 11p14.3-15.1,
ﬂanked by the recombinant markers D11S1308 and
Figure 1 GDD phenotype and mutations. A, Affected female from Japanese family at age 16 years; facial deformity characteristic of the
GDD phenotype is shown. B, Three-dimensional image of computed tomography. The image shows jaw lesions occupying alveolar processes.
Projections around teeth (asterisk) are metal artifacts caused by teeth ﬁllings. C, D, Radiographs of upper and lower limbs showing diaphyseal
cortical thickening of tubular bones (arrows). E, Physical map of the GDD critical region and genomic structure of GDD1. Exons (ﬁlled boxes)
and UTRs (gray box) are shown. F, Sequence analysis showing heterozygous T-to-C and T-to-G changes in the codon for Cys356 in affected
members of the Japanese and African American families, respectively. SSCP patterns show cosegregation of mutant alleles (mu) with the disease
phenotype. Individuals available for analyses are indicated (arrows).
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D11S930, where no bone-disease loci have beenmapped
(Tsutsumi et al. 2003). On the basis of data from the
University of California–Santa Cruz (UCSC) genome
browser (UCSC Genome Bioinformatics Web site), the
GDD critical region was shown to contain eight known
genes (NAV2, HTATIP2, PRMT3, SLC6A5, NELL1,
SLC17A6, FANCF, and GAS2) (ﬁg. 1E). By use of DNA
samples from the Japanese family, these genes were
screened for mutations by direct DNA sequencing with
primer pairs that ampliﬁed all exons and exon-intron
boundaries, but no mutations were detected.
In a further search for GDD candidate genes, we pri-
oritized uncharacterized ESTs (expressed sequence tag
sequences) that mapped to the critical region. A cDNA
clone sequence AL833271 from skeletal muscle had a
size of ∼6.7 kb, exhibited the polyadenylation signal
(AATAAA) at the 3′ end, and included an ORF of 2,742
bp encoding a protein of 913 amino acids, with a mo-
lecular mass of 107.20 kDa. A human skeletal muscle
cDNA was ampliﬁed by 5′ rapid ampliﬁcation of cDNA
ends (RACE) (Invitrogen), revealing that AL833271 was
a full-length cDNA sequence. We named this gene
“GDD1” (GenBank accession number AB125267).
Aligning the UCSC July 2003 human genome assem-
bly (UCSC Genome Bioinformatics Web site) with
AL833271 revealed that GDD1 consisted of 22 exons
and spanned ∼90 kb of genomic DNA (ﬁg. 1E). The
initiation and stop codons (ATG and TAA) were present
in exons 1 and 22, respectively.
Oligonucleotide primers were designed to amplify and
directly sequence the 22 exons, along with the ﬂanking
exon-intron boundaries (table A1 [online only]). Screen-
ing DNA from the Japanese family revealed that 14 af-
fected members were heterozygous for a missense mu-
tation in exon 11 at codon 356 (C356R; TGTrCGT),
whereas 8 unaffected members had no mutation. Also,
DNA sequencing in two affected members, but not in
two unaffected members, from a new family of African
American origin with GDD revealed another missense
mutation at the same codon 356 (C356G; TGTrGGT).
SSCP analysis conﬁrmed that mutant alleles of GDD1
cosegregated with the disease phenotype in each fam-
ily (ﬁg. 1F). Neither of these two mutations was found
in 488 Japanese or 80 African American control
individuals.
The GDD1 protein showed no signiﬁcant similarity
to any other known protein or protein classes. However,
amino acid sequence analysis using the helix-prediction
program TMpred suggested that GDD1 contains eight
transmembrane-spanning domains, with the N- and C-
termini located in the cytosol (ﬁg. 2A and 2B). MOTIF
and PSORT II also predicted ﬁve putative N-glycosy-
lation sites and a potential endoplasmic reticulum (ER)
retention signal (Teasdale and Jackson 1996) at the C-
terminus (AKST), respectively (ﬁg. 2C). On the other
hand, BLAST analysis showed potentially orthologous
sequences in zebraﬁsh, fruit ﬂy, and mosquito, indicating
that the GDD1 protein is evolutionarily conserved.
Mouse GDD1 (mGDD1) cDNA was isolated from
mouse skeletal muscle cDNA (Clontech) and completed
by RT-PCR by use of a mouse genome sequence with
high homology to human GDD1 (hGDD1), which was
identiﬁed through Ensembl (Ensembl Genome Browser
Web site). The protein predicted from mGDD1 cDNA
sequence shared 79% amino acid identity with the hu-
man GDD1 protein (hGDD1). Multiple sequence align-
ment of hGDD1with its orthologs revealed that the eight
cysteine residues at positions 342, 353, 356, 360, 369,
601, 606, and 804 in the putative extracellular loops
were absolutely conserved in all species (ﬁg. 2C). These
cysteine residues are expected to play an important role
in the formation of intrachain disulﬁde bonds that are
crucial for an appropriate tertiary structure of the
hGDD1 protein, and the mutations of C356R and
C356G probably compromise the conformation (ﬁg.
2B).
The pattern of tissue expression was determined by a
581-bp fragment corresponding to the 3′ UTR of
hGDD1 cDNA, hybridized to a human Multiple Tissue
Northern Blot (Clontech). Twomajor transcripts of∼7.5
and ∼4.5 kb were detected in skeletal muscle, heart, and
pancreas (ﬁg. 3A). Since affected tissues were not rep-
resented on this blot, we examined levels of hGDD1
gene expression in explant cultures of normal human
osteoblasts and periodontal ligament cells, as well as in
nonskeletal tissues (Human Total RNA Master Panel
[Clontech]), by RT-PCR analysis. Expression of hGDD1
was detected in brain, heart, kidney, lung, and skeletal
muscle at usual conditions (30 cycles) andwas detectable
after 40 cycles in explant cultures of osteoblasts and
periodontal ligament cells, as well as the other tissues
shown in ﬁgure 3B. Quantitative real-timeRT-PCRanal-
ysis of various tissues derived from one mouse aged 8
wk revealed that mGDD1 was highly expressed in bone
tissues, such as calvaria, femur, and mandible (ﬁg. 3C).
Although this result appears to be in contrast with the
low level of hGDD1 gene expression in human osteo-
blasts, we believe that the discrepancy in expression level
might arise from differences in the samples used (explant
cultures after three or four passages versus fresh bone
tissues). The expression proﬁle in vivo could not be re-
produced completely in explant cultures.
To search the potential impact of the identiﬁed mu-
tations, we transfected COS-7 cells with a plasmid ex-
pression vector containing the wild-type or mutant full-
length hGDD1 cDNA tagged with V5 epitope at its 3′
end. On reducing SDS-PAGE and western blot analysis,
anti-V5 antibody detected a bandmigrating at∼110 kDa
in the whole-cell lysate of each transfectant (ﬁg. 4A).
The band size was consistent with the predicted molec-
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Figure 2 Characterization of the human GDD1 protein. A, The hydrophobic proﬁle of the human GDD1 protein, which indicates that
it contains eight potential transmembrane domains. B, Predicted membrane topology of the human GDD1 protein. The locations of the N-
glycosylation sites (projections), the eight cysteine residues absolutely conserved in all species (C), the potential ER retention signal (gray box),
and the mutated cysteine residue are shown. C, ClustalW multiple sequence alignment of GDD1 orthologs. Protein similarity between the GDD1
orthologs is relatively high, with the human protein 79%, 56%, 40%, and 41% identical to the mouse, zebraﬁsh, fruit ﬂy, and mosquito,
respectively. The alignment shows that the eight cysteine residues in the putative extracellular loops are absolutely conserved in all species
(highlighted in black). The predicted transmembrane domains (boxed), the putative N-glycosylation sites (red), and the potential ER retention
signal (blue) are indicated. Identical (*), strictly conserved (:), and conserved (.) sites are indicated below the ClustalW alignment of GDD1
orthologs.
ular mass from the hGDD1-V5 cDNA sequence. Im-
munoﬂuorescent staining of transfected cells with anti-
V5 antibody showed that the wild-type hGDD1 protein
formed a distinct reticular pattern around the nucleus
and colocalized with calreticulin, an ER-speciﬁc marker
(Smith and Koch 1989) (ﬁg. 4B). It further showed that
cells overexpressing each mutant hGDD1 protein, but
not the wild-type hGDD1 protein, decreased cell ad-
hesion and changed the cell morphology to a round
shape (ﬁg. 4C). However, these rounded cells showed
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Figure 3 Expression analysis of GDD1 mRNA in human and mouse tissues. A, A human Multiple Tissue Northern Blot (Clontech),
hybridized with a 32P-labeled 581-bp fragment of hGDD1 cDNA (upper panel). The blot was rehybridized with 32P-labeled b-actin cDNA as
a loading control (lower panel). B, RT-PCR analysis for hGDD1 mRNA in human tissues, normal human osteoblasts, and normal human
periodontal ligament cells. We used osteoblasts isolated from jawbone specimens (hOB1–4) by use of the explant culture method (Hahn et al.
1988), osteoblasts from femur (hOB5 [Cambrex]), and periodontal ligament cells (hPDL) isolated from extracted tooth by use of the explant
culture method. These cells were maintained in a-minimum essential medium containing 10% fetal bovine serum, 50 mg/ml of L-ascorbic acid,
50 U/ml penicillin, and 50 mg/ml streptomycin, and used at passage 3–4 for extraction of total RNA. A 348-bp fragment of hGDD1 cDNA
was ampliﬁed by use of primers from exons 9 and 12. PCR was performed by use of Platinum Taq (Invitrogen) at 95C for 2 min, followed
by 30 or 40 cycles of 94C for 30 s, 55C for 30 s, and 72C for 30 s. A 452-bp fragment of hGAPDH cDNA was ampliﬁed as an internal
control. C, Relative expression of mGDD1 (normalized to mGAPDH) in mouse tissues. A real-time, two-step RT-PCR analysis was performed
by use of SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7900HT system (Applied Biosystems). Total RNA was isolated
from various tissues of mouse aged 8 wk and reverse transcribed into random-primed ﬁrst-strand cDNA. Speciﬁc PCR primer sets for mGDD1
and mGAPDH were designed to avoid ampliﬁcation of genomic DNA. The relative quantity was determined by the standard curve method,
in which the standard curves were generated by 10-fold serial dilution of mouse skeletal muscle cDNA. The normalized values were derived
from the ratio of the relative quantity of mGDD1 for each sample to that of mGAPDH for that sample. Data are presented as the means 
SD of three independent experiments.
no features of apoptotic cell death, such as chromatin
condensation or DNA fragmentation (data not shown).
In the present study, GDD1 mutations were identiﬁed
in two families with different genetic backgrounds who
were both affected with GDD. We believe that mutant
alleles at GDD1 are responsible for the disease for sev-
eral reasons, in addition to the fact that the gene maps
to the critical region. In each of the two families, mutant
alleles of GDD1 cosegregated with the disease pheno-
type. Both missense mutations involved the cysteine res-
idue at amino acid 356, which is evolutionarily con-
served in human, mouse, zebraﬁsh, fruit ﬂy, and
mosquito, further suggesting the biological signiﬁcance
of these mutations. None of the mutations was observed
in normal chromosomes. hGDD1 was shown to be ex-
pressed in human osteoblasts and periodontal ligament
cells, consistent with the disease phenotype and the pre-
vious studies suggesting that cemento-osseous lesions of
the jaws originate in the periodontal ligament (Waldron
and Giansanti 1973; Neville and Albenesius 1986). In
mouse, mGDD1 mRNA was shown to be abundant in
fresh bone tissues.
Although hGDD1 seemed to be an integral membrane
protein localizing in the ER, its function remains un-
known. As a clue to the function, membrane proteins
localizing in the ER are often involved in protein pro-
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Figure 4 Expression of the hGDD1 protein in COS-7 cells. A,
Western blot analysis to conﬁrm expression of the wild-type and mu-
tant hGDD1 proteins. Whole-cell lysates from COS-7 cells transfected
with each plasmid expression vector containing thewild-type (hGDD1-
V5) or mutant (C356R or C356G) hGDD1 cDNA tagged with V5
epitope at its 3′ end were subjected to reducing SDS-PAGE, andwestern
blot analysis was performed by use of anti-V5 antibody (Invitrogen).
For control transfection, pcDNA6/lacZ-V5 (Invitrogen) was used to
represent the expression of an unrelated exogenous protein.B,Cellular
localization of the wild-type hGDD1 protein. V5-tagged hGDD1 pro-
tein (hGDD1-V5) formed a distinct reticular pattern around the nu-
cleus (green). Costaining with antibody against the calreticulin ER-
speciﬁc marker (red) showed colocalization with the hGDD1 protein
(yellow). C, Immunoﬂuorescent staining with anti-V5 antibody, which
shows that the only cells overexpressing each mutant hGDD1 protein
decrease cell adhesion and change the cell morphology to a round
shape.
cessing, protein folding, or calcium homeostasis. The
amino acid sequence of hGDD1 lacks calcium or ATP-
binding motifs and contains no homology to heat-shock
proteins or GroEL, thereby providing no evidence for a
direct involvement of hGDD1 in protein folding or cal-
cium sequestration (Ma and Hendershot 2001). Instead,
the presence of eight predicted transmembrane-spanning
domains suggests that hGDD1 might function in the
transport of ions or other small molecules across mem-
branes. We speculate that hGDD1 might function as an
intracellular calcium-release channel and that it might
regulate a calcium-dependent signaling pathway. Vari-
ous substances that inﬂuence bone remodeling modify
the intracellular calcium concentration in osteoblasts
(Meszaros and Karin 1995). There are two sources of
intracellular calcium in osteoblasts: (1) inﬂow from the
extracellular space and (2) release from intracellular
stores, such as the ER. The release of calcium from the
ER is a ubiquitous signal in many cells, including os-
teoblasts (Kumagai et al. 1991; Ljunggren et al. 1991).
Given that each mutant hGDD1 induces excess calcium
release from the ER, the alteration in cell shape (as de-
scribed above) could occur through modulation of the
cytoskeleton (Pettit and Fay 1998). Further studies of
the function of hGDD1 should yield crucial insights into
the pathogenesis of GDD.
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